X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

DCTH

Closed

Delcath Systems Inc

12.76
-0.84 (-6.18%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.6
Day's Range: 12.65 - 13.46
Send
When Written:
 
5.75
Delcath Systems Inc. is a medical technology company that specializes in the development and commercialization of innovative therapies for the treatment of cancer. The company's primary focus is on the treatment of liver cancer, which is one of the most difficult-to-treat forms of cancer.

Delcath's flagship product is the Hepatic ChemoSAT Delivery System, which is a minimally invasive, catheter-based system that delivers high-dose chemotherapy directly to the liver. This targeted approach minimizes the exposure of healthy tissue to chemotherapy, while maximizing the concentration of the drug in the tumor.

The company is headquartered in New York City and has operations in Europe and Asia. Delcath is publicly traded on the NASDAQ stock exchange under the ticker symbol DCTH.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.15
X